Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Agarwal'S Eye HospitalBOM:526783 +2.21%94 EV-to-EBITDA is 17.75 as of Aug. 31, 2026, which is 114% above its 10-year median of 8.28. GuruFocus rates BOM:526783 with a GF Score™ of 94/100 and a GF Value™ of ₹5,534.73 (Fairly Valued). The stock has 3 warning signs investors should review. Among 515 Healthcare Providers & Services companies, Dr Agarwal'S Eye Hospital ranks worse than 70.49% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Dr Agarwal'S Eye Hospital's enterprise value is ₹28,114 Mil.
Dr Agarwal'S Eye Hospital's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ₹1,584 Mil. Therefore, Dr Agarwal'S Eye Hospital's EV-to-EBITDA for today is 17.75.
The historical rank and industry rank for Dr Agarwal'S Eye Hospital's EV-to-EBITDA or its related term are showing as below:
BOM:526783'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 1.94 Med: 8.28 Max: 27.55
Current: 17.74
During the past 13 years, the highest EV-to-EBITDA of Dr Agarwal'S Eye Hospital was 27.55. The lowest was 1.94. And the median was 8.28.
BOM:526783's EV-to-EBITDA is ranked worse than 70.49% of 515
companies
in the Healthcare Providers & Services industry
Industry Median: 10.61
vs BOM:526783: 17.74
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Dr Agarwal'S Eye Hospital (BOM:526783) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Dr Agarwal'S Eye Hospital's PE Ratio (TTM) for today is calculated as:
Dr Agarwal'S Eye Hospital's share price for today is ₹5340.55.
Dr Agarwal'S Eye Hospital's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹158.780.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:526783 vs HCA, THC, EHC: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Dr Agarwal'S Eye Hospital's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Agarwal'S Eye Hospital EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dr Agarwal'S Eye Hospital's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Dr Agarwal'S Eye Hospital's EV-to-EBITDA falls into.
Dr Agarwal'S Eye Hospital's current Enterprise Value is ₹28,114 Mil.
Dr Agarwal'S Eye Hospital's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,584 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Agarwal'S Eye Hospital (BOM:526783) has a EV-to-EBITDA of 17.75 as of Aug. 31, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Dr Agarwal'S Eye Hospital. This is 114% above median its historical median of 8.28. Over the past decade, Dr Agarwal'S Eye Hospital's EV-to-EBITDA has ranged from 1.94 to 27.55. According to the industry distribution chart, Dr Agarwal'S Eye Hospital ranks #363 out of 515 companies in the Healthcare Providers & Services industry, placing it in the top 70.5%.
Is Dr Agarwal'S Eye Hospital's EV-to-EBITDA too high?
Dr Agarwal'S Eye Hospital's current EV-to-EBITDA of 17.75 is 114% above median its 10-year median of 8.28. Over the past 10 years, this metric has ranged from a low of 1.94 to a high of 27.55. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.61. Dr Agarwal'S Eye Hospital's value of 17.75 is 67.3% above this industry median. Based on the distribution chart, Dr Agarwal'S Eye Hospital ranks #363 out of 515 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Dr Agarwal'S Eye Hospital has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr Agarwal'S Eye Hospital's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Agarwal'S Eye Hospital ranks #363 out of 515 companies for EV-to-EBITDA. This places Dr Agarwal'S Eye Hospital in the lower half of its industry. The industry median EV-to-EBITDA is 10.61. Dr Agarwal'S Eye Hospital's value of 17.75 is 67.3% above this benchmark. Historically, Dr Agarwal'S Eye Hospital's own EV-to-EBITDA has ranged from 1.94 to 27.55 over the past decade. While the company's 10-year median is 8.28 vs. the industry median of 10.61, Dr Agarwal'S Eye Hospital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.61, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Agarwal'S Eye Hospital's current EV-to-EBITDA of 17.75 is 67.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Dr Agarwal'S Eye Hospital. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Agarwal'S Eye Hospital's current EV-to-EBITDA is 17.75, which is 114% above median its own 10-year median of 8.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Agarwal'S Eye Hospital stock overvalued right now?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital (BOM:526783) is currently considered Fairly Valued. The stock's GF Value™ is ₹5,534.73, compared to a current price of ₹5,340.55 — trading 3.5% below its estimated fair value. The current EV-to-EBITDA is 17.75, which is 114% above median its 10-year median of 8.28 and 67.3% above the Healthcare Providers & Services industry median of 10.61. Dr Agarwal'S Eye Hospital's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Dr Agarwal'S Eye Hospital (BOM:526783), the current EV-to-EBITDA is 17.75 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Agarwal'S Eye Hospital (BOM:526783) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital stock appears to be undervalued.
The current stock price of ₹5,340.55 is trading 3.5% below its estimated GF Value™ of ₹5,534.73.
GuruFocus considers Dr Agarwal'S Eye Hospital to be Fairly Valued.
Key valuation signals for BOM:526783:
EV-to-EBITDA: 17.75 (114% above median its 10-year median of 8.28)
GF Value™: ₹5,534.73 vs. price of ₹5,340.55 (3.5% below fair value)
Industry Position: 67.3% above the Healthcare Providers & Services median (#363 of 515)
No single metric tells the full story. See the BOM:526783 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Agarwal'S Eye Hospital Ltd is a provider of eye care and related services. The company is predominantly engaged in running, owning and managing eye care hospitals, opticals, pharmacies, and related services. It operates across various locations in India and provides solutions like Refractive Surgery, Lasik Surgery, Oculoplasty, Laser Cataract Surgery, and SMILE Eye Surgery among others.
94GF Score
Get the complete analysis for BOM:526783
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526783 has been successfully added to your 
